SPC
AYTU icon

Sigma Planning Corp’s AYTU BioPharma AYTU Stock Holding History

Sigma Planning Corp’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-850
Closed -$3.21K – 1299
2022
Q4 		$3.21K Hold
850
– – ﹤0.01% 1254
2022
Q3 		$3K Buy
+850
New +$6.45K ﹤0.01% 1258
2022
Q1 		– Sell
-506
Closed -$14K – 1374
2021
Q4 		$14K Buy
506
+5
+1% +$216 ﹤0.01% 1375
2021
Q3 		$29K Sell
501
-83
-14% -$6.23K ﹤0.01% 1360
2021
Q2 		$58K Buy
584
+48
+9% +$5.63K ﹤0.01% 1392
2021
Q1 		$81K Buy
+536
New +$85.1K ﹤0.01% 1293
2020
Q4 		– Sell
-116
Closed -$28K – 1201
2020
Q3 		$28K Buy
116
+44
+61% +$11.3K ﹤0.01% 1046
2020
Q2 		$21K Sell
72
-5
-6% -$1.51K ﹤0.01% 1044
2020
Q1 		$23K Buy
+77
New +$14.9K ﹤0.01% 900

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sigma Planning Corp's AYTU Position: Q1 2023 in Review

Sigma Planning Corp sold out of AYTU BioPharma (AYTU) in Q1 2023, closing a stake of 850 shares — an estimated $3.21K sold.

Sigma Planning Corp first reported a position in AYTU in Q1 2020 and held it in 9 quarters. The position peaked at $81K in Q1 2021. 21 funds tracked by Wall St. Rank hold AYTU as of Q1 2023.

  • Sigma Planning Corp reported no remaining AYTU BioPharma position as of Q1 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 850 AYTU BioPharma shares in Q1 2023, an estimated $3.21K.
  • Sigma Planning Corp first reported a position in AYTU BioPharma in Q1 2020 and held it in 9 quarters.
  • Sigma Planning Corp's AYTU BioPharma position peaked at $81K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2023.

Based on Sigma Planning Corp's 13F filing for Q1 2023, filed 8 May 2023.